Jianmin Pharmaceutical Group Co.,Ltd. (SHA:600976)
China flag China · Delayed Price · Currency is CNY
34.41
+0.34 (1.00%)
Feb 4, 2026, 2:45 PM CST

SHA:600976 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Jan '21
Cash & Equivalents
175.22163.17305.12219.33301.6691.17
Trading Asset Securities
947.77954.19694.46641.38538.63485.79
Cash & Short-Term Investments
1,1231,117999.58860.71840.28576.96
Cash Growth
6.15%11.78%16.13%2.43%45.64%21.10%
Accounts Receivable
1,030957.561,150868.66674.6586.18
Other Receivables
22.7925.7631.4349.6421.438.98
Receivables
1,053983.331,181918.29696.03595.17
Inventory
309.66354.31450.85362.88222.6229
Other Current Assets
101.66146.43134.06162.85104.5111.96
Total Current Assets
2,5872,6012,7662,3051,8631,513
Property, Plant & Equipment
656.86595.59450.7417.65396.65371.76
Long-Term Investments
797.33772.18650.42444.94326.85318.86
Goodwill
0.210.210.210.210.210.21
Other Intangible Assets
25.9328.1928.8731.1632.9822.16
Long-Term Deferred Tax Assets
129.49129.49139.44117.27118.3385.23
Long-Term Deferred Charges
130.61130.78111.2791.6687.6498.38
Other Long-Term Assets
9.919.7421.1432.5630.017.65
Total Assets
4,3384,2784,1683,4402,8562,417
Accounts Payable
697.8742.22782.91611.06374.92375.86
Accrued Expenses
36.29574.78724.73620.32592.57486.13
Short-Term Debt
55140.979.4522.524520
Current Portion of Leases
1.926.395.127.346.10.08
Current Income Taxes Payable
74.9152.7466.2349.6871.7554.36
Current Unearned Revenue
21.6761.4341.1982.5237.0441.68
Other Current Liabilities
736.31166.66157.31140.25191.8589.63
Total Current Liabilities
1,6241,7451,8571,5341,3191,068
Long-Term Debt
30.994----
Long-Term Leases
31.0924.4330.2923.4820.370.08
Long-Term Unearned Revenue
44.1546.5518.6112.1827.7225.44
Long-Term Deferred Tax Liabilities
7.27.25.625.970.840.82
Total Liabilities
1,7371,8271,9111,5751,3681,094
Common Stock
153.4153.4153.4153.4153.4153.4
Additional Paid-In Capital
522.73523.42520.68509.17421.5301.46
Retained Earnings
1,9061,7581,5801,212931.06863.71
Treasury Stock
---6.76-14.99-25.08-1.66
Total Common Equity
2,5822,4352,2481,8601,4811,317
Minority Interest
17.8915.038.784.997.046.35
Shareholders' Equity
2,6002,4502,2561,8651,4881,323
Total Liabilities & Equity
4,3384,2784,1683,4402,8562,417
Total Debt
119175.71114.8653.3471.4820.16
Net Cash (Debt)
1,004941.65884.72807.37768.81556.8
Net Cash Growth
14.75%6.44%9.58%5.02%38.07%16.87%
Net Cash Per Share
6.646.195.795.305.063.62
Filing Date Shares Outstanding
153.4153.4153.82152.78151.97151.97
Total Common Shares Outstanding
153.4153.4153.82152.78151.97153.32
Working Capital
963.3856.33908.95771.06544.18445.34
Book Value Per Share
16.8315.8814.6112.179.748.59
Tangible Book Value
2,5562,4072,2191,8291,4481,295
Tangible Book Value Per Share
16.6615.6914.4211.979.538.44
Buildings
-287.12284.12289.38298.05342
Machinery
-314.22312.36301.9251.25173.95
Construction In Progress
-206.6841.4817.1916.7343.32
Source: S&P Global Market Intelligence. Standard template. Financial Sources.